Back

Trends in mechanical circulatory support use and outcomes of patients with cardiogenic shock in Japan, 2010-2020: a nationwide inpatient database study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Prognostication and mechanical support in cardiogenic shock Cardiogenic Shock ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Yuji Nishimoto

Toyonaka Municipal Hospital, Toyonaka (Japan)

8 More presentations in this session

Presentation thumbnail
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis
Doctor G. Chatzis (Marburg, DE)
Abstract Slides Video
Presentation thumbnail
Characteristics and prognostic implications of pre-shock and normotensive cardiogenic shock in the Critical Care Cardiology Trials Network Registry
Doctor S. Patel (Boston, US)
Abstract Slides Video
Presentation thumbnail
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Doctor T. Unoki (Kumamoto, JP)
Abstract Slides Video
Presentation thumbnail
Validation of SAVE score and the value of serum lactate in patients admitted for cardiogenic shock treated with VA-ECMO
Doctor A. Bello (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
Vasoactive medication requirements in the first 24 hours of cardiogenic shock: association with mortality and mechanical circulatory support
Doctor D. Sarma (Nashville, US)
Abstract Slides Video

Access the full session

Session thumbnail
Prognostication and mechanical support in cardiogenic shock

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The impact of hospital volume on the prognosis of patients with cardiogenic shock requiring mechanical circulatory support
thumbnail
Congress Presentation
Factors associated with 30-day mortality in patients receiving mechanical circulatory support for cardiogenic shock
thumbnail
Congress Presentation
Mechanical circulatory support in cardiogenic shock: a 5-year single center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources